Exclusive-FDA Drug Center Head Expected to Leave After Commissioner’s Exit, Sources Say
By Yasmeen Abutaleb and Michael Erman WASHINGTON, May 15 (Reuters) – The acting head of the U.S. Food and Drug Administration’s drug center, Tracey Beth Hoeg, is expected to leave the agency just days after Commissioner Marty Makary resigned, according to three people familiar with internal planning. Hoeg, an epidemiologist and sports physician who cast …